Clinical Trial Update: Pneumococcal Vaccine in Untreated CLL Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing a pneumococcal vaccine in patients with untreated chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Chronic Lymphocytic Leukemia | Phase 3 | Status: COMPLETED